New York State Common Retirement Fund Biohaven Pharmaceutical Holding CO Ltd. Transaction History

New York State Common Retirement Fund

$76.2 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$144.95 - $152.29 $251,198 - $263,918	-1,733 Reduced 3.7%	45,063 $6.81 Million
Q2 2022 Aug 04, 2022	SELL	$83.14 - $145.99 $1.86 Million - $3.27 Million	-22,430 Reduced 32.4%	46,796 $6.82 Million
Q1 2022 May 05, 2022	BUY	$110.08 - $142.92 $381,537 - $495,360	3,466 Added 5.27%	69,226 $8.21 Million
Q4 2021 Feb 02, 2022	BUY	$99.73 - $148.48 $70,908 - $105,569	711 Added 1.09%	65,760 $9.06 Million
Q3 2021 Nov 02, 2021	BUY	$98.85 - $138.91 $706,184 - $992,373	7,144 Added 12.34%	65,049 $9.04 Million
Q2 2021 Aug 02, 2021	BUY	$65.78 - $105.02 $216,942 - $346,355	3,298 Added 6.04%	57,905 $5.62 Million
Q1 2021 May 11, 2021	SELL	$64.07 - $91.75 $82,009 - $117,440	-1,280 Reduced 2.29%	54,607 $3.73 Million
Q4 2020 Feb 08, 2021	SELL	$65.07 - $98.24 $84,590 - $127,712	-1,300 Reduced 2.27%	55,887 $4.79 Million
Q3 2020 Nov 05, 2020	BUY	$59.04 - $77.95 $82,656 - $109,130	1,400 Added 2.51%	57,187 $3.72 Million
Q2 2020 Aug 07, 2020	BUY	$29.01 - $74.23 $237,882 - $608,686	8,200 Added 17.23%	55,787 $4.08 Million
Q1 2020 May 06, 2020	BUY	$27.51 - $57.29 $93,121 - $193,926	3,385 Added 7.66%	47,587 $1.62 Million
Q4 2019 Feb 05, 2020	SELL	$40.86 - $57.65 $151,182 - $213,305	-3,700 Reduced 7.72%	44,202 $2.41 Million
Q3 2019 Nov 07, 2019	BUY	$37.38 - $49.47 $171,948 - $227,562	4,600 Added 10.62%	47,902 $2 Million
Q2 2019 Aug 09, 2019	BUY	$39.79 - $67.01 $281,951 - $474,832	7,086 Added 19.57%	43,302 $1.9 Million
Q1 2019 May 08, 2019	BUY	$34.52 - $53.29 $72,492 - $111,909	2,100 Added 6.16%	36,216 $1.86 Million
Q4 2018 Feb 08, 2019	SELL	$29.75 - $42.9 $68,335 - $98,541	-2,297 Reduced 6.31%	34,116 $1.26 Million
Q2 2018 Aug 10, 2018	SELL	$23.62 - $42.29 $64,600 - $115,663	-2,735 Reduced 6.99%	36,413 $1.44 Million
Q1 2018 May 10, 2018	BUY	$22.49 - $34.56 $639,795 - $983,162	28,448 Added 265.87%	39,148 $1.01 Million
Q4 2017 Feb 13, 2018	SELL	$20.44 - $35.56 $169,529 - $294,934	-8,294 Reduced 43.67%	10,700 $289,000
Q2 2017 Aug 11, 2017	BUY	N/A	18,994	18,994 $475,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account